LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 26.1%, EPS grew 700.0%, free cash flow grew 55.2% and total debt fell 5.08%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

11.74 0.63 −5.09%
Market cap
$4.7B
P/E
88.3×
Fwd P/E
58.5×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a

LifeStance Health Group, Inc. (LFST) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, LifeStance Health Group, Inc. (LFST) trades at a P/E ratio of 88.3×. Over the past ten years it has ranged from 0.0× (December 2025) to 301× (January 2026); the current reading is higher than 87% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 284× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 80.5× (20.36%)
Mar 2026 101× (64.38%)
Dec 2025 284× —
Sep 2025 0.0× —
22 more quarters

Against its own ten years

Low 0.0× High 301×
Ten-year median 0.0×
Current reading's percentile 87

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on LFST